Correlations between serum levels of beta amyloid, cerebrospinal levels of tau and phospho tau, and delayed response tasks in young and aged cynomolgus monkeys (Macaca fascicularis)

Journal of Medical Primatology

Volumn 42, Issue 3, 2013, Pages 137-146

  Darusman, H S ^a,b   Sajuthi, D ^b   Kalliokoski, O ^a   Jacobsen, K R ^a   Call, J ^c   Schapiro, S J ^a,d   Gjedde, A ^a,e,f   Abelson, K S P ^a   Hau, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

^c MAX PLANCK INSTITUTE FOR EVOLUTIONARY ANTHROPOLOGY   (Germany)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e AARHUS UNIVERSITY   (Denmark)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Biomarker; Memory test

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

ADOLESCENT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; LONG TERM MEMORY; MACACA FASCICULARIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RESPONSE TIME; SHORT TERM MEMORY; TASK PERFORMANCE; AGING; ANIMAL; BLOOD; DISEASE MODEL; MEMORY; PSYCHOLOGY;

ANIMALIA; MACACA FASCICULARIS;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FEMALE; MACACA FASCICULARIS; MALE; MEMORY; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84877682185     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/jmp.12044     Document Type: Article

References (39)

1. Mangialasche F, Solomon A, Winblad B, Mecoccci P, Kivipelto M: Alzheimer's disease: clinical trials and drug development. Lancet Neurol 2010; 9:702-16.
2. Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, Delacourte A, Fox NC, Galasko D, Gautier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway M, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P: Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010; 9:1118-27.
3. Salmon DP, Bondi MW: Neuropsychological assessment of dementia. Annu Rev Psychol 2009; 60:257-82.
4. Blennow K, de Leon MJ: Zetterberg: Alzheimer's disease. Lancet 2006; 368:387-403.
5. Dickerson BC, Sperling RA: Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insight from functional MRI studies. Neuropsychologia 2008; 46:1624-35.
6. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, SternY, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-46.
7. Albert MS, De Kosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carillo MC, Thies B, Phelps CH: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:270-9.
8. Perrin R, Fagan AM, Holtzman DM: Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 2009; 461:916-22.
9. Berti V, Pupi A, Mosconi L: PET/CT in diagnosis of dementia. Ann N Y Acad Sci 2011; 1228:81-92.
10. Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N, Zipfel GJ, Holtzman DM: Amyloid-β dynamics correlate with neurological status in the injured human brain. Science 2008; 321:1221-124.
11. Blennow K, Hampel H, Weiner M: Zetterberg: cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010; 6:131-44.
12. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde ALW, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K: Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nature 2010; 9: 560-74
13. Fagan AM, Holtzman D: Cerebrospinal fluid biomarkers of Alzheimer's disease. Biomark Med 2010; 4:51-63.
14. Casadesus G, Arendash G, Laferla F, McDonald M: Animal models of Alzheimer's disease. Int J Alz Dis 2010; doi: 10.4061/2010/606357.
15. Kimura N, Tanemura K, Nakamura S, Takashima A, Ono F, Sakakibara I, Ishii Y, Kyuwa S, Yoshikawa Y: Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem Biophys Res Commun 2003; 310:303-11.
16. Nakamura S, Nakayama H, Goto N, Ono F, Sakakibara I, Yoshikawa Y: Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys. J Med Primatol 1998; 27:244-52.
17. Oikawa N, Kimura N, Yanagisawa K: Alzheimer-type tau pathology in advanced old non- human primate brains harboring substantial amyloid deposition. Brain Res 2010; 1315:137-49.
18. Rodriguez JS, Paule MG: Working memory delayed response tasks in monkeys. In: Methods of Behavior Analysis in Neuroscience 2nd edition. Buccafusco JJ (ed). Boca Raton, FL: CRC Press, 2009; http://www.ncbi.nlm.nih.gov/books/NBK5227. Accessed on 15 March 2013.
19. Nagahara AH, Bernot T, Tuszynski MH: Age related cognitive deficits in rhesus monkeys mirror human deficits on an automated test battery. J Neurobiology 2010; 31:1020-31.
20. Bartus RT, Dean RL III: Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps. Psychopharmacol 2009; 202:15-36.
21. Amici F, Aureli F, Call J: Monkeys and apes: are their cognitive skills really so different? Am J Phys Anthropol 2010; 143:188-97.
22. Barth J, Call J: Tracking the displacement of objects: a series of tasks with great apes (Pan troglodytes, Pan paniscus, Gorilla gorilla and Pongo pygmaeus) and young children (Homo sapiens). J Exp Psychol Anim Behav Process 2006; 32:239-52.
23. Beran MJ, Beran MM, Menzel CR: Spatial memory and monitoring of hidden items through spatial displacements by chimpanzees (Pan troglodytes). Comp Psychol 2005; 119:14-22.
24. Call J: Object permanence in orangutans (Pongo pygmaeus), chimpanzees (Pan troglodytes) and children (Homo sapiens). Comp Psychol 2001; 115:159-71.
25. Martin-Ordas G, Call J: Memory processing in great apes: the effect of time and sleep. Biol Lett 2011; 7:829-32.
26. Tomasello M, Call J: Primate Cognition. New York: Oxford University Press, 1997.
27. Sweller J: Cognitive load during problem solving: effects on learning. Cog Sci 1988; 12:257-85.
28. Moss MB, Moore TL, Schettler SP, Killiany R, Rosene D: Successful vs unsuccessful aging in the rhesus monkey. In: Brain Aging: Model, Methods and Mechanism. Riddle DR (ed). Boca Raton, FL: CRC Press, 2007; 21-38.
29. Bowen WH, Koch G: Determination of age in monkeys (Macaca irus) on the basis of dental development. Lab Anim 1970; 4:113-23.
30. Swindler DR: Primate Dentistry An Introduction to the Teeth of Non-human Primates. Cambridge: Cambridge University Press, 2002.
31. Andreasen N, Blennow K: CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin Neurol Neurosurg 2005; 107:165-73.
32. Noelker C, Hampel H, Dodel R: Blood-based protein biomarkers for diagnosing and classification of neurodegenerative disease. Mol Diagn Ther 2011; 15:83-102.
33. Hau J, Nilsson M, Skovgaard-Jensen HJ, de Souza A, Wandall LT: Analysis of animal serum proteins using antisera against human analogous proteins. A study of immunological cross reaction between human and animal serum proteins. Scand J Lab Anim Sci 1990; 17:3-7.
34. Hardy J, Selkoe DJ: The Amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-6.
35. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 2006; 59:512-9.
36. Augustinack JC, Schenider A, Mandelkow EM, Hyman BT: Specific tau phosphorylation sited correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 2002; 103:26-35.
37. Laske C: Blood-based biomarkers in AD- a silver lining on the horizon. Nat Rev Neurol 2012; 8:541-2.
38. Small JA, Kemper S, Lyons K: Sentence repetition and processing resources in Alzheimer's disease. Brain Lang 2000; 75:232-58.
39. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agustino RB: The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol 2000; 57:808-13.